Role of miR‐145 in human laryngeal squamous cell carcinoma
暂无分享,去创建一个
Mustafa Ozen | Michael Ittmann | M. Ittmann | M. Ozen | Omer Faruk Karatas | Betul Yuceturk | Ilknur Suer | Mehmet Yilmaz | Harun Cansiz | Mustafa Solak | O. Karatas | M. Solak | Betul Yuceturk | H. Cansız | I. Suer | M. Yılmaz
[1] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[2] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[3] Xinwei Chen,et al. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. , 2013, International journal of clinical and experimental pathology.
[4] B. Novitch,et al. Vertebrate neurogenesis is counteracted by Sox1–3 activity , 2003, Nature Neuroscience.
[5] Jialing Yuan,et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. , 2007, Cancer research.
[6] C. Cicione,et al. Molecular profile and cellular characterization of human bone marrow mesenchymal stem cells: donor influence on chondrogenesis. , 2010, Differentiation; research in biological diversity.
[7] Yi-long Wu,et al. Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical Treatment , 2013, PloS one.
[8] Y. Toiyama,et al. Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy , 2009, Annals of Surgical Oncology.
[9] R. Xiang,et al. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. , 2011, Journal of molecular cell biology.
[10] M. Hussain,et al. MicroRNAs and human diseases: diagnostic and therapeutic potential , 2014, Cell and Tissue Research.
[11] Jing Gong,et al. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. , 2010, Cancer research.
[12] Duan Ma,et al. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma , 2013, Head & neck.
[13] H. Becher,et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis , 2011, European Archives of Oto-Rhino-Laryngology.
[14] R. Morton,et al. Epidemiology of laryngeal cancer. , 1982, Clinical otolaryngology and allied sciences.
[15] C. Creighton,et al. Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.
[16] Jing Liang,et al. The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer* , 2008, Journal of Biological Chemistry.
[17] G. Pan,et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.
[18] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[19] S. Kasper. Exploring the Origins of the Normal Prostate and Prostate Cancer Stem Cell , 2008, Stem Cell Reviews.
[20] E. Chu,et al. Laryngeal cancer: diagnosis and preoperative work-up. , 2008, Otolaryngologic clinics of North America.
[21] D. Steindler,et al. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. , 2010, The Journal of urology.
[22] E. Karaca,et al. MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients , 2013, Molecular Biology Reports.
[23] Rajvir Dahiya,et al. MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer , 2010, Cancer.
[24] T. Tammela,et al. MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.
[25] Shi-Ming Chen,et al. Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data. , 2013, Cancer genetics.
[26] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..